Evidence map›Paper›PMID 30076573›Full record

Trial reportJournal of general internal medicine2018

Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial.

Jeffrey M Ashburner, Steven J Atlas, Shaan Khurshid, Lu-Chen Weng, Olivia L Hulme, Yuchiao Chang, Daniel E Singer, Patrick T Ellinor, Steven A Lubitz

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of general internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02950285 (Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02950285 nacompletednot on this map

Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation

TypeinterventionalSponsorMassachusetts General HospitalRan2017 to 2017Enrolled2,336ConditionsAtrial FibrillationArmsBaseline alert
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Initial Precipitants and Recurrence of Atrial Fibrillation.Circulation. Arrhythmia and electrophysiology · 2020
    Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jeffrey M AshburnerDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Steven J AtlasDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Shaan KhurshidDepartment of Medicine, Harvard Medical School, Boston, MA, USA.
Lu-Chen WengCardiovascular Research Center and Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA, USA.
Olivia L HulmeCardiovascular Research Center and Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA, USA.
Yuchiao ChangDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Daniel E SingerDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Patrick T EllinorCardiovascular Research Center and Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA, USA.
Steven A LubitzCardiovascular Research Center and Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA, USA. slubitz@mgh.harvard.edu.
Massachusetts General Hospital · USHarvard University · US

Funding

Atrial Fibrillation: Bridging genetic discovery and clinical associationsK23HL114724 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI LUBITZ, STEVEN A · 2013 to 2017
$893k
NHLBI NIH HHS K23 HL114724
6 · The paper itself

Abstract

backgroundOral anticoagulants reduce the risk of stroke in patients with atrial fibrillation. However, many patients with atrial fibrillation at elevated stroke risk are not treated with oral anticoagulants.

objectiveTo test whether electronic notifications sent to primary care physicians increase the proportion of ambulatory patients prescribed oral anticoagulants.

designRandomized controlled trial conducted from February to May 2017 within 18 practices in an academic primary care network.

participantsPrimary care physicians (n = 175) and their patients with atrial fibrillation, at elevated stroke risk, and not prescribed oral anticoagulants.

interventionPatients of each physician were randomized to the notification or usual care arm. Physicians received baseline email notifications and up to three reminders with patient information, educational material and primary care guidelines for anticoagulation management, and surveys in the notification arm. MAIN MEASURES: The primary outcome was the proportion of patients prescribed oral anticoagulants at 3 months in the notification (n = 972) vs. usual care (n = 1364) arms, compared using logistic regression with clustering by physician. Secondary measures included survey-based physician assessment of reasons why patients were not prescribed oral anticoagulants and how primary care physicians might be influenced by the notification. KEY

resultsOver 3 months, a small proportion of patients were newly prescribed oral anticoagulants with no significant difference in the notification (3.9%, 95% CI 2.8-5.3%) and usual care (3.2%, 95% CI 2.4-4.2%) arms (p = 0.37). The most common, non-exclusive reasons why patients were not on oral anticoagulants included atrial fibrillation was transient (30%) or paroxysmal (12%), patient/family declined (22%), high bleeding risk (20%), fall risk (19%), and frailty (10%). For 95% of patients, physicians stated they would not change their management after reviewing the alert.

conclusionsElectronic physician notification did not increase anticoagulation in patients with atrial fibrillation at elevated stroke risk. Primary care physicians did not prescribe anticoagulants because they perceived the bleeding risk was too high or stroke risk was too low.

trial registrationClinicalTrials.gov identifier NCT02950285.

Indexed as

Administration, OralAgedAged, 80 and overAnticoagulantsAtrial FibrillationElectronic PrescribingFemaleGuideline AdherenceHumansMaleMedical Order Entry SystemsAnticoagulantsatrial fibrillationelectronic notificationsoral anticoagulationprimary carerandomized controlled trial

Identifiers

PMID30076573
PMCPMC6258628
OpenAlexW2886291731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.